Literature DB >> 6889850

Neurotoxic effects of cisplatin therapy.

T J Walsh, A W Clark, I M Parhad, W R Green.   

Abstract

Swelling of the optic disc and loss of tendon reflexes developed in a 3 1/2-year-old girl after 11 high-dose courses of cisplatin (cis-dichlorodiammine platinum [II]) therapy for recurrent sacrococcygeal teratoma. Postmortem examination demonstrated optic disc swelling; the spinal cord showed loss of myelinated fibers and gliosis of the dorsal columns. To our knowledge this case is the first in which the neuropathologic changes associated with cisplatin therapy have been demonstrated by postmortem examination.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889850     DOI: 10.1001/archneur.1982.00510230045013

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  25 in total

1.  Monocular visual loss in a patient undergoing cisplatin chemotherapy.

Authors:  F Gonzalez; D Menendez; F Gomez-Ulla
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Authors:  Iryna A Khasabova; Sergey Khasabov; Justin Paz; Catherine Harding-Rose; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

3.  Severe sensorimotor neuropathy after cisplatin therapy.

Authors:  M Pagès; A M Pagès; L Bories-Azeau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

4.  Cisplatin-induced gastric paresis.

Authors:  S C Cohen; J E Mollman
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Transient blindness and seizure associated with cisplatin therapy.

Authors:  M T Cattaneo; V Filipazzi; E Piazza; E Damiani; G Mancarella
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

6.  Cisplatin neuropathy with Lhermitte's sign.

Authors:  A C Williams; M H Cullen; I G Haynes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

Review 7.  Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Authors:  Jacqueline B Stone; Lisa M DeAngelis
Journal:  Nat Rev Clin Oncol       Date:  2015-09-22       Impact factor: 66.675

8.  In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.

Authors:  C C Verstappen; A A Geldof; T J Postma; J J Heimans
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

9.  Electric shock-like sensations in 42 cancer patients: clinical characteristics and distinct etiologies.

Authors:  A Lossos; T Siegal
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

10.  Carboplatin-Induced Bilateral Papilledema: A Case Report.

Authors:  N Fischer; J Stuermer; B Rodic; M Pless
Journal:  Case Rep Oncol       Date:  2009-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.